Rite Aid Corporation Allergy Relief Drug Facts

allergy relief by

Drug Labeling and Warnings

allergy relief by is a Otc medication manufactured, distributed, or labeled by Rite Aid Corporation. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ALLERGY RELIEF- cetirizine hydrochloride capsule, liquid filled 
Rite Aid Corporation

----------

Rite Aid Corporation Allergy Relief Drug Facts

Active ingredient (in each capsule)

Cetirizine HCl 10 mg

Purpose

Antihistamine

Uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

• runny nose
• sneezing
• itchy, watery eyes
• itching of the nose or throat

Warnings

Do not use

if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.

Ask a doctor before use if you have

liver or kidney disease. Your doctor should determine if you need a different dose.

Ask a doctor or pharmacist before use if you are

taking tranquilizers or sedatives.

When using this product

• drowsiness may occur
• avoid alcoholic drinks
• alcohol, sedatives, and tranquilizers may increase drowsiness
• be careful when driving a motor vehicle or operating machinery

Stop use and ask a doctor if

an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding:

• if breast-feeding: not recommended
• if pregnant: ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

Directions

• adults and children 6 years and over:

  one 10 mg capsule once daily; do not take more than one 10 mg capsule in 24 hours. A 5 mg product may be appropriate for less severe symptoms.

• adults 65 years and over:

  ask a doctor

• children under 6 years of age:

  ask a doctor

• consumers with liver or kidney disease:

  ask a doctor

Other information

• avoid high humidity and excessive heat above 40°C (104°F)
• protect from light

Inactive ingredients

butylated hydroxytoluene, gelatin, glycerin, mannitol, pharmaceutical ink, polyethylene glycol 400, purified water, sodium hydroxide, sorbitan, sorbitol

Questions or comments?

1-800-719-9260

Package/Label Principal Display Panel

Compare to the active ingredient of Zyrtec® Liquid Gels

ORIGINAL PRESCRIPTION STRENGTH

ALLERGY RELIEF

CETIRIZINE HYDROCHLORIDE CAPSULES, 10 mg

ANTIHISTAMINE

INDOOR & OUTDOOR ALLERGIES

24 HOUR RELIEF OF

Sneezing – Runny nose

Itchy, watery eyes

Itchy throat or nose

24 Hour

ACTUAL SIZE

40 LIQUID GELS**

**LIQUID FILLED CAPSULES

ALLERGY RELIEF 
cetirizine hydrochloride capsule, liquid filled

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 11822-0457
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
CETIRIZINE HYDROCHLORIDE (UNII: 64O047KTOA) (CETIRIZINE - UNII:YO7261ME24)	CETIRIZINE HYDROCHLORIDE	10 mg

Inactive Ingredients
Ingredient Name	Strength
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)
GELATIN, UNSPECIFIED (UNII: 2G86QN327L)
GLYCERIN (UNII: PDC6A3C0OX)
MANNITOL (UNII: 3OWL53L36A)
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
WATER (UNII: 059QF0KO0R)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
SORBITAN (UNII: 6O92ICV9RU)
SORBITOL (UNII: 506T60A25R)

Product Characteristics
Color	YELLOW	Score	no score
Shape	OVAL	Size	13mm
Flavor		Imprint Code	10
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 11822-0457-1	1 in 1 CARTON	11/30/2020	05/01/2023
1		40 in 1 BOTTLE; Type 0: Not a Combination Product
2	NDC: 11822-0457-0	1 in 1 CARTON	12/03/2020	05/01/2023
2		25 in 1 BOTTLE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
ANDA	ANDA207235	11/30/2020	05/01/2023

Labeler - Rite Aid Corporation (014578892)

Revised: 2/2026

Document Id: 662c407b-49b1-401a-ba76-940dc56d4804

34390-5

Set id: c0e58e3d-bdb1-4752-b0ff-5301bc32db91

Version: 3

Effective Time: 20260225